标题
Nanotechnology-based strategies against SARS-CoV-2 variants
作者
关键词
-
出版物
Nature Nanotechnology
Volume 17, Issue 10, Pages 1027-1037
出版商
Springer Science and Business Media LLC
发表日期
2022-08-19
DOI
10.1038/s41565-022-01174-5
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Estimates of SARS-CoV-2 Omicron Variant Severity in Ontario, Canada
- (2022) Ana Cecilia Ulloa et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Omicron severity: milder but not mild
- (2022) Joshua Nealon et al. LANCET
- Three-dose vaccination elicits neutralising antibodies against omicron
- (2022) Mary Wu et al. LANCET
- Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift
- (2022) Elisabetta Cameroni et al. NATURE
- Engineered ACE2 decoy mitigates lung injury and death induced by SARS-CoV-2 variants
- (2022) Lianghui Zhang et al. Nature Chemical Biology
- Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial
- (2022) Katherine V. Houser et al. NATURE MEDICINE
- An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies
- (2022) Laura A. VanBlargan et al. NATURE MEDICINE
- Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant
- (2022) Emi Takashita et al. NEW ENGLAND JOURNAL OF MEDICINE
- Challenges in Inferring Intrinsic Severity of the SARS-CoV-2 Omicron Variant
- (2022) Roby P. Bhattacharyya et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent Persons
- (2022) Annika Rössler et al. NEW ENGLAND JOURNAL OF MEDICINE
- Protection against the Omicron Variant from Previous SARS-CoV-2 Infection
- (2022) Heba N. Altarawneh et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination
- (2022) Rolando Pajon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Circulating ACE2-expressing extracellular vesicles block broad strains of SARS-CoV-2
- (2022) Lamiaa El-Shennawy et al. Nature Communications
- Are There Hidden Genes in DNA/RNA Vaccines?
- (2022) Christopher A. Beaudoin et al. Frontiers in Immunology
- Circular RNA vaccines against SARS-CoV-2 and emerging variants
- (2022) Liang Qu et al. CELL
- Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant
- (2022) Nick Andrews et al. NEW ENGLAND JOURNAL OF MEDICINE
- Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa
- (2022) Juliet R. C. Pulliam et al. SCIENCE
- Design of SARS-CoV-2 hFc-Conjugated Receptor-Binding Domain mRNA Vaccine Delivered via Lipid Nanoparticles
- (2021) Uri Elia et al. ACS Nano
- Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape
- (2021) Paul-Albert Koenig et al. SCIENCE
- Covid-19: Moderna plans booster doses to counter variants
- (2021) Janice Hopkins Tanne BMJ-British Medical Journal
- The renaissance of chemically generated bispecific antibodies
- (2021) Peter Szijj et al. Nature Reviews Chemistry
- Single-domain antibodies make a difference
- (2021) Xavier Saelens et al. SCIENCE
- Immunity to SARS-CoV-2 variants of concern
- (2021) Daniel M. Altmann et al. SCIENCE
- An engineered decoy receptor for SARS-CoV-2 broadly binds protein S sequence variants
- (2021) Kui K. Chan et al. Science Advances
- Glycyrrhizic Acid Nanoparticles as Antiviral and Anti-inflammatory Agents for COVID-19 Treatment
- (2021) Zhaoyan Zhao et al. ACS Applied Materials & Interfaces
- Membrane Nanoparticles Derived from ACE2-Rich Cells Block SARS-CoV-2 Infection
- (2021) Cheng Wang et al. ACS Nano
- SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies
- (2021) Markus Hoffmann et al. CELL
- Antibody evasion by the P.1 strain of SARS-CoV-2
- (2021) Wanwisa Dejnirattisai et al. CELL
- Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization
- (2021) Pengfei Wang et al. Cell Host & Microbe
- Antigen‐dependent multistep differentiation of T follicular helper cells and its role in SARS‐CoV‐2 infection and vaccination
- (2021) Dirk Baumjohann et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Effects of SARS-CoV-2 variants on vaccine efficacy and response strategies
- (2021) Lianlian Bian et al. Expert Review of Vaccines
- Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice
- (2021) Raoul De Gasparo et al. NATURE
- Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses
- (2021) Kevin O. Saunders et al. NATURE
- Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies
- (2021) Delphine Planas et al. NATURE MEDICINE
- Nanotechnology approaches for global infectious diseases
- (2021) Ameya R. Kirtane et al. Nature Nanotechnology
- mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection
- (2021) Leonidas Stamatatos et al. SCIENCE
- SARS-CoV-2 evolution and vaccines: cause for concern?
- (2021) Thomas C Williams et al. Lancet Respiratory Medicine
- Single-component, self-assembling, protein nanoparticles presenting the receptor binding domain and stabilized spike as SARS-CoV-2 vaccine candidates
- (2021) Linling He et al. Science Advances
- Secreted Expression of mRNA‐Encoded Truncated ACE2 Variants for SARS‐CoV‐2 via Lipid‐Like Nanoassemblies
- (2021) Min Li et al. ADVANCED MATERIALS
- In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies
- (2021) Dapeng Li et al. CELL
- Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum
- (2021) Chang Liu et al. CELL
- Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
- (2021) Alexandra C. Walls et al. CELL
- Structures of SARS-CoV-2 B.1.351 neutralizing antibodies provide insights into cocktail design against concerning variants
- (2021) Shuo Du et al. CELL RESEARCH
- Neutralization of SARS‐CoV‐2 by highly potent, hyperthermostable, and mutation‐tolerant nanobodies
- (2021) Thomas Güttler et al. EMBO JOURNAL
- First identification of SARS-CoV-2 Lambda (C.37) variant in Southern Brazil
- (2021) Priscila Lamb Wink et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- A cluster of the new SARS‐CoV‐2 B.1.621 lineage in Italy and sensitivity of the viral isolate to the BNT162b2 vaccine
- (2021) Serena Messali et al. JOURNAL OF MEDICAL VIROLOGY
- Serum Neutralizing Activity of mRNA-1273 Against SARS-CoV-2 Variants
- (2021) Angela Choi et al. JOURNAL OF VIROLOGY
- Lipid Nanoparticle RBD-hFc mRNA Vaccine Protects hACE2 Transgenic Mice against a Lethal SARS-CoV-2 Infection
- (2021) Uri Elia et al. NANO LETTERS
- BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants
- (2021) Jianying Liu et al. NATURE
- Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants
- (2021) Zhiqiang Ku et al. NATURE
- Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants
- (2021) Jianliang Xu et al. NATURE
- Programmable icosahedral shell system for virus trapping
- (2021) Christian Sigl et al. NATURE MATERIALS
- Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis
- (2021) Angela Choi et al. NATURE MEDICINE
- Cell-mimicking nanodecoys neutralize SARS-CoV-2 and mitigate lung injury in a non-human primate model of COVID-19
- (2021) Zhenhua Li et al. Nature Nanotechnology
- Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients
- (2021) Nassim Kamar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients
- (2021) Victoria G. Hall et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3
- (2021) Ann R. Falsey et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 Variants and Vaccines
- (2021) Philip R. Krause et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months
- (2021) Stephen J. Thomas et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhalable nanocatchers for SARS-CoV-2 inhibition
- (2021) Han Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants
- (2021) Lingshu Wang et al. SCIENCE
- Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice
- (2021) David R. Martinez et al. SCIENCE
- Protective Effects of Astodrimer Sodium 1% Nasal Spray Formulation against SARS-CoV-2 Nasal Challenge in K18-hACE2 Mice
- (2021) Jeremy R. A. Paull et al. Viruses-Basel
- Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes
- (2021) Dapeng Sun et al. Nature Communications
- Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies
- (2021) Allison J. Greaney et al. Nature Communications
- Engineered ACE2 receptor therapy overcomes mutational escape of SARS-CoV-2
- (2021) Yusuke Higuchi et al. Nature Communications
- Covid-19 booster vaccines: What we know and who’s doing what
- (2021) Elisabeth Mahase BMJ-British Medical Journal
- Covid-19 vaccination: evidence of waning immunity is overstated
- (2021) Jake Scott et al. BMJ-British Medical Journal
- Nanoparticles in the clinic: An update post COVID ‐19 vaccines
- (2021) Aaron C. Anselmo et al. Bioengineering & Translational Medicine
- Engineering Extracellular Vesicles Enriched with Palmitoylated ACE2 as COVID‐19 Therapy
- (2021) Feng Xie et al. ADVANCED MATERIALS
- Principles for designing an optimal mRNA lipid nanoparticle vaccine
- (2021) Edo Kon et al. CURRENT OPINION IN BIOTECHNOLOGY
- Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses
- (2021) Mohamad-Gabriel Alameh et al. IMMUNITY
- Surface Glycan Modification of Cellular Nanosponges to Promote SARS-CoV-2 Inhibition
- (2021) Xiangzhao Ai et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic
- (2021) Salim S Abdool Karim et al. LANCET
- Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity
- (2021) Carolina Lucas et al. NATURE
- Nanotechnology offers alternative ways to fight COVID-19 pandemic with antivirals
- (2021) Mark Peplow NATURE BIOTECHNOLOGY
- Low-dose in vivo protection and neutralization across SARS-CoV-2 variants by monoclonal antibody combinations
- (2021) Vincent Dussupt et al. NATURE IMMUNOLOGY
- Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection
- (2021) Ital Nemet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Plasma Neutralization of the SARS-CoV-2 Omicron Variant
- (2021) Fabian Schmidt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months
- (2021) Einav G. Levin et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 vaccine protection and deaths among US veterans during 2021
- (2021) Barbara A. Cohn et al. SCIENCE
- Covid-19: Pfizer’s paxlovid is 89% effective in patients at risk of serious illness, company reports
- (2021) Elisabeth Mahase BMJ-British Medical Journal
- Mechanism of a COVID-19 nanoparticle vaccine candidate that elicits a broadly neutralizing antibody response to SARS-CoV-2 variants
- (2021) Yi-Nan Zhang et al. Science Advances
- Advantages and Prospects of Tag/Catcher Mediated Antigen Display on Capsid-Like Particle-Based Vaccines
- (2020) Kara-Lee Aves et al. Viruses-Basel
- Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
- (2020) Vanessa Monteil et al. CELL
- Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
- (2020) Jun Lan et al. NATURE
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Spiky Nanostructures with Geometry-matching Topography for Virus Inhibition
- (2020) Chuanxiong Nie et al. NANO LETTERS
- Cellular Nanosponges Inhibit SARS-CoV-2 Infectivity
- (2020) Qiangzhe Zhang et al. NANO LETTERS
- Dexamethasone nanomedicines for COVID-19
- (2020) Twan Lammers et al. Nature Nanotechnology
- Immune-mediated approaches against COVID-19
- (2020) Helena F. Florindo et al. Nature Nanotechnology
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2
- (2020) Kui K. Chan et al. SCIENCE
- Old Drugs for a New Virus: Repurposed Approaches for Combating COVID-19
- (2020) Sirle Saul et al. ACS Infectious Diseases
- The coronavirus is mutating — does it matter?
- (2020) Ewen Callaway NATURE
- Decoy nanoparticles protect against COVID-19 by concurrently adsorbing viruses and inflammatory cytokines
- (2020) Lang Rao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Engineered ACE2 receptor traps potently neutralize SARS-CoV-2
- (2020) Anum Glasgow et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Human recombinant soluble ACE2 in severe COVID-19
- (2020) Alexander Zoufaly et al. Lancet Respiratory Medicine
- A materials-science perspective on tackling COVID-19
- (2020) Zhongmin Tang et al. Nature Reviews Materials
- Stopping Membrane-Enveloped Viruses with Nanotechnology Strategies: Toward Antiviral Drug Development and Pandemic Preparedness
- (2020) Bo Kyeong Yoon et al. ACS Nano
- ACE2: from protection of liver disease to propagation of COVID-19
- (2020) Fiona J. Warner et al. CLINICAL SCIENCE
- SARS-CoV-2 mRNA Vaccines Foster Potent Antigen-Specific Germinal Center Responses Associated with Neutralizing Antibody Generation
- (2020) Katlyn Lederer et al. IMMUNITY
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- An ACE2 Microbody Containing a Single Immunoglobulin Fc Domain Is a Potent Inhibitor of SARS-CoV-2
- (2020) Takuya Tada et al. Cell Reports
- Insights from nanotechnology in COVID-19 treatment
- (2020) Zhongmin Tang et al. Nano Today
- Fetal programming and the angiotensin-(1-7) axis: a review of the experimental and clinical data
- (2019) Andrew M. South et al. CLINICAL SCIENCE
- Designer DNA architecture offers precise and multivalent spatial pattern-recognition for viral sensing and inhibition
- (2019) Paul S. Kwon et al. Nature Chemistry
- Targeted selection of HIV-specific antibody mutations by engineering B cell maturation
- (2019) Kevin O. Saunders et al. SCIENCE
- Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses
- (2018) Norbert Pardi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- New Routes and Opportunities for Modular Construction of Particulate Vaccines: Stick, Click, and Glue
- (2018) Karl D. Brune et al. Frontiers in Immunology
- Therapeutic treatment of Zika virus infection using a brain-penetrating antiviral peptide
- (2018) Joshua A. Jackman et al. NATURE MATERIALS
- Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection
- (2015) Laurent Detalle et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Novel RAAS agonists and antagonists: clinical applications and controversies
- (2015) Cesar A. Romero et al. Nature Reviews Endocrinology
- Nanobodies: Natural Single-Domain Antibodies
- (2013) Serge Muyldermans Annual Review of Biochemistry
- Pharmacokinetics and Pharmacodynamics of Recombinant Human Angiotensin-Converting Enzyme 2 in Healthy Human Subjects
- (2013) Manuel Haschke et al. CLINICAL PHARMACOKINETICS
- DNA Origami: The Art of Folding DNA
- (2011) Barbara Saccà et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Nanobodies®: New ammunition to battle viruses
- (2011) Peter Vanlandschoot et al. ANTIVIRAL RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now